Home / Latest Reports / Liquid Biopsy Market

Liquid Biopsy Market By Application (Therapy Selection for Metastatic Breast Cancer (MBS), Molecular Health Monitoring and Therapy Selection for Other Metastatic Cancer), Sample Type (Blood Sample-based, Urine Sample-based and Other Bio Fluids), Biomaker Type (Circulating Tumor Cells (CTC), Exosomes and Circulating Tumor DNA (ctDNA)) and Technology (Single Gene Analysis (PCR Microarrays) and Multi-gene-parallel Analysis) - Global Industry Analysis & Forecast to 2027

Published On : August 2018 Pages : 180 Category: Biotechnology Report Code : HC081243

Request Sample Inquiry Before Buying Request for Customization Check Discount

Industry Outlook and Trend Analysis

The Liquid Biopsy is expected to gain considerable market share by 2027, while registering itself at a significant compound annual growth rate (CAGR) during the forecast period. Liquid biopsy is a rapidly emerging alternative for customary tumor biopsies, created out of the requirement to gain the most amounts of molecular data regarding cancer with minimal surgical invasion. With quick improvements in NGS technology, liquid biopsies are assessed to take prime position with regards to cancer related investigation and probe. Besides, with foreseen positive outcomes from various clinical trials for the advancement of these tests and resulting bigger scaled clinical trials exhibiting viability, it is likely that the testing procedure will serve a more extensive base of patient in atomic checking settings.

Application Outlook and Trend Analysis

The advent of complete commercialization of liquid biopsies is anticipated to be significantly problematic. Three major applications of liquid biopsy can be therapy selection for other metastatic cancers, therapy selection tool for metastatic breast cancers, and molecular health monitoring. With the rising frequency of metastatic cancer over the globe, the therapy selection tool for metastatic breast cancers section is anticipated to hold an extensive share in the market all through the estimate time frame.

Sample Type Outlook and Trend Analysis

Because of the various previous applications and techniques for purification, blood sampling is the most commonly used example for liquid biopsy studies and product improvements. Circulating tumor cells, cell-free DNA and exosomes and in addition microvesicles can be recognized in blood test. This brings about higher rate of adoption of liquid biopsy through blood testing. The next generation sequencing (NGS) technology is used in this for identification of numerous transformations in various genes.

Biomaker Type Outlook and Trend Analysis

There are around 8-10 fluid biopsy tests on the basis of CTCs and ctDNA that are as of now commercialized. Moreover, more than 30 tests in view of each of the three of these biomarkers are in clinical improvement by some major market players. Commercialization of these tests in the offing is evaluated to profit the development of the general market.

Technology Outlook and Trend Analysis

Based on technology, single gene analysis and multi gene analysis are the two main techniques used. PCR-based sequencing is used for analysis of changes in disease specific genes though analysis of numerous diseases all the while can be completed by using the NGS multiplex testing. PCR microarray and NGS technology are both viewed as vital for examination of previously mentioned biomarkers to perform any liquid biopsy analysis.

Regional Outlook and Trend Analysis

North America was at the forefront of the market in 2017, trailed by Europe. The development of the area can be credited to recent regulatory approvals by CE for business application of these liquid biopsy tests. Nonetheless, Asia Pacific is probably going to enroll exceptional CAGR amid the gauge time frame as governments and organizations are endeavoring to continue developing growth predominance rates in the area under control. Japan, India, and China are the major contributing nations to the area's development.

Competitive Insights

The leading players in the market are Personal Genome Diagnostics, TrovaGene, Guardant Health, Raindance Technologies, Adaptive Biotechnologies, Qiagen, Cynvenio Biosystems Inc, Biocept and NeoGenomics. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Liquid Biopsy Market is segmented by regions as follows-

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Liquid Biopsy Market, By Application, Estimates and Forecast, 2017-2027 ($Million)

·         Therapy Selection for Metastatic Breast Cancer (MBS)

·         Molecular Health Monitoring

·         Therapy Selection for Other Metastatic Cancer

·         Liquid Biopsy Market, By Sample Type, Estimates and Forecast, 2017-2027 ($Million)

·         Blood Sample-based

·         Urine Sample-based

·         Other Bio Fluids

·         Liquid Biopsy Market, By Biomaker Type, Estimates and Forecast, 2017-2027 ($Million)

·         Circulating Tumor Cells (CTC)

·         Exosomes

·         Circulating Tumor DNA (ctDNA)

·         Liquid Biopsy Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)

·         Single Gene Analysis (PCR Microarrays)

·         Multi-gene-parallel Analysis

·         Liquid Biopsy Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Liquid Biopsy Market, By Country

o    U.S. Liquid Biopsy Market

o    Canada Liquid Biopsy Market

o    Mexico Liquid Biopsy Market

o    Europe

§  Europe Liquid Biopsy Market, By Country

o    Germany Liquid Biopsy Market

o    UK Liquid Biopsy Market

o    France Liquid Biopsy Market

o    Russia Liquid Biopsy Market

o    Italy Liquid Biopsy Market

o    Rest of Europe Liquid Biopsy Market

o    Asia-Pacific

§  Asia-Pacific Liquid Biopsy Market, By Country

o    China Liquid Biopsy Market

o    Japan Liquid Biopsy Market

o    South Korea Liquid Biopsy Market

o    India Liquid Biopsy Market

o    Southeast Asia Liquid Biopsy Market

o    Rest of Asia-Pacific Liquid Biopsy Market

o    South America

§  South America Liquid Biopsy Market

o    Brazil Liquid Biopsy Market

o    Argentina Liquid Biopsy Market

o    Columbia Liquid Biopsy Market

o    Rest of South America Liquid Biopsy Market

o    Middle East and Africa

§  Middle East and Africa Liquid Biopsy Market

o    Saudi Arabia Liquid Biopsy Market

o    UAE Liquid Biopsy Market

o    Egypt Liquid Biopsy Market

o    Nigeria Liquid Biopsy Market

o    South Africa Liquid Biopsy Market

o    Rest of MEA Liquid Biopsy Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2027)

4.1.2.  Canada Market States and Outlook (2017-2027)

4.1.3.  Mexico Market States and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2027)

4.2.2.  France Market States and Outlook (2017-2027)

4.2.3.  UK Market States and Outlook (2017-2027)

4.2.4.  Russia Market States and Outlook (2017-2027)

4.2.5.  Italy Market States and Outlook (2017-2027)

4.2.6.  Rest of Europe Market States and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2027)

4.3.2.  Japan Market States and Outlook (2017-2027)

4.3.3.  Korea Market States and Outlook (2017-2027)

4.3.4.  India Market States and Outlook (2017-2027)

4.3.5.  Southeast Asia Market States and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market States and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2027)

4.4.2.  Argentina Market States and Outlook (2017-2027)

4.4.3.  Columbia Market States and Outlook (2017-2027)

4.4.4.  Rest of South America Market States and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market States and Outlook (2017-2027)

4.5.3.  Egypt Market States and Outlook (2017-2027)

4.5.4.  Nigeria Market States and Outlook (2017-2027)

4.5.5.  South Africa Market States and Outlook (2017-2027)

4.5.6.  Turkey Market States and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market States and Outlook (2017-2027)

5.       Liquid Biopsy Market, By Application

5.1.     Introduction

5.2.     Global Liquid Biopsy Revenue and Market Share by Application (2017-2027)

5.2.1.  Global Liquid Biopsy Revenue and Revenue Share by Application (2017-2027)

5.3.     Therapy Selection for Metastatic Breast Cancer (MBS)

5.3.1.  Global Therapy Selection for Metastatic Breast Cancer (MBS) Revenue and Growth Rate (2017-2027)

5.4.     Molecular Health Monitoring

5.4.1.  Global Molecular Health Monitoring Revenue and Growth Rate (2017-2027)

5.5.     Therapy Selection for Other Metastatic Cancer

5.5.1.  Global Therapy Selection for Other Metastatic Cancer Revenue and Growth Rate (2017-2027)

6.       Liquid Biopsy Market, By Sample Type

6.1.     Introduction

6.2.     Global Liquid Biopsy Revenue and Market Share by Sample Type (2017-2027)

6.2.1.  Global Liquid Biopsy Revenue and Revenue Share by Sample Type (2017-2027)

6.3.     Blood Sample-based

6.3.1.  Global Blood Sample-based Revenue and Growth Rate (2017-2027)

6.4.     Urine Sample-based

6.4.1.  Global Urine Sample-based Revenue and Growth Rate (2017-2027)

6.5.     Other Bio Fluids

6.5.1.  Global Other Bio Fluids Revenue and Growth Rate (2017-2027)

7.       Liquid Biopsy Market, By Biomaker Type

7.1.     Introduction

7.2.     Global Liquid Biopsy Revenue and Market Share by Biomaker Type (2017-2027)

7.2.1.  Global Liquid Biopsy Revenue and Revenue Share by Biomaker Type (2017-2027)

7.3.     Circulating Tumor Cells (CTC)

7.3.1.  Global Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2027)

7.4.     Exosomes

7.4.1.  Global Exosomes  Revenue and Growth Rate (2017-2027)

7.5.     Circulating Tumor DNA (ctDNA)

7.5.1.  Global Circulating Tumor DNA (ctDNA) Revenue and Growth Rate (2017-2027)

8.       Liquid Biopsy Market, By Technology

8.1.     Introduction

8.2.     Global Liquid Biopsy Revenue and Market Share by Technology (2017-2027)

8.2.1.  Global Liquid Biopsy Revenue and Revenue Share by Technology (2017-2027)

8.3.     Single Gene Analysis (PCR Microarrays)

8.3.1.  Global Single Gene Analysis (PCR Microarrays) Revenue and Growth Rate (2017-2027)

8.4.     Multi-gene-parallel Analysis

8.4.1.  Global Multi-gene-parallel Analysis Revenue and Growth Rate (2017-2027)

9.       Liquid Biopsy Market, By Region

9.1.     Introduction

9.2.     Global Liquid Biopsy Revenue and Market Share by Regions

9.2.1.  Global Liquid Biopsy Revenue by Regions (2017-2027)

9.3.     North America Liquid Biopsy by Countries

9.3.1.  North America Liquid Biopsy Revenue and Growth Rate (2017-2027)

9.3.2.  North America Liquid Biopsy Revenue (Million USD) by Countries (2017-2027)

9.3.3.  United States

9.3.3.1.  United States Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.4.  Canada

9.3.4.1.  Canada Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.5.  Mexico

9.3.5.1.  Mexico Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.     Europe Liquid Biopsy by Countries

9.4.1.  Europe Liquid Biopsy Revenue and Growth Rate (2017-2027)

9.4.2.  Europe Liquid Biopsy Revenue (Million USD) by Countries (2017-2027)

9.4.3.  Germany

9.4.3.1.  Germany Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.4.  France

9.4.4.1.  France Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.5.  UK

9.4.5.1.  UK Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.6.  Russia

9.4.6.1.  Russia Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.7.  Italy

9.4.7.1.  Italy Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.8.  Rest of Europe

9.4.8.1.  Rest of Europe Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.     Asia-Pacific Liquid Biopsy by Countries

9.5.1.  Asia-Pacific Liquid Biopsy Revenue and Growth Rate (2017-2027)

9.5.2.  Asia-Pacific Liquid Biopsy Revenue (Million USD) by Countries (2017-2027)

9.5.3.  China

9.5.3.1.  China Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.4.  Japan

9.5.4.1.  Japan Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.5.  Korea

9.5.5.1.  Korea Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.  India

9.5.6.1.  India Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.7.  Southeast Asia

9.5.7.1.  Southeast Asia Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.8.  Rest of Asia-Pacific

9.5.8.1.  Rest of Asia-Pacific Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.     South America Liquid Biopsy by Countries

9.6.1.  South America Liquid Biopsy Revenue and Growth Rate (2017-2027)

9.6.2.  South America Liquid Biopsy Revenue (Million USD) by Countries (2017-2027)

9.6.3.  Brazil

9.6.3.1.  Brazil Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.4.  Argentina

9.6.4.1.  Argentina Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.5.  Columbia

9.6.5.1.  Columbia Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.6.  Rest of South America

9.6.6.1.  Rest of South America Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.     Middle East and Africa Liquid Biopsy by Countries

9.7.1.  Middle East and Africa Liquid Biopsy Revenue and Growth Rate (2017-2027)

9.7.2.  Middle East and Africa Liquid Biopsy Revenue (Million USD) by Countries (2017-2027)

9.7.3.  Saudi Arabia

9.7.3.1.  Saudi Arabia Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.4.  United Arab Emirates

9.7.4.1.  United Arab Emirates Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.5.  Egypt

9.7.5.1.  Egypt Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.6.  Nigeria

9.7.6.1.  Nigeria Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.7.  South Africa

9.7.7.1.  South Africa Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.8.  Turkey

9.7.8.1.  Turkey Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.9.  Rest of Middle East and Africa

9.7.9.1.  Rest of Middle East and Africa Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

10.    Company Profiles

10.1. Personal Genome Diagnostics

10.1.1.      Business Overview

10.1.2.       Service Portfolio

10.1.3.      Strategic Developments

10.1.4.       Revenue and Market Share

10.2. TrovaGene

10.2.1.      Business Overview

10.2.2.       Service Portfolio

10.2.3.      Strategic Developments

10.2.4.       Revenue and Market Share

10.3. Guardant Health

10.3.1.      Business Overview

10.3.2.       Service Portfolio

10.3.3.      Strategic Developments

10.3.4.       Revenue and Market Share

10.4. Raindance Technologies

10.4.1.      Business Overview

10.4.2.       Service Portfolio

10.4.3.      Strategic Developments

10.4.4.       Revenue and Market Share

10.5. Adaptive Biotechnologies

10.5.1.      Business Overview

10.5.2.       Service Portfolio

10.5.3.      Strategic Developments

10.5.4.       Revenue and Market Share

10.6. Qiagen

10.6.1.      Business Overview

10.6.2.       Service Portfolio

10.6.3.      Strategic Developments

10.6.4.       Revenue and Market Share

10.7. Cynvenio Biosystems Inc

10.7.1.      Business Overview

10.7.2.       Service Portfolio

10.7.3.      Strategic Developments

10.7.4.       Revenue and Market Share

10.8. Biocept

10.8.1.      Business Overview

10.8.2.       Service Portfolio

10.8.3.      Strategic Developments

10.8.4.       Revenue and Market Share

10.9. NeoGenomics

10.9.1.      Business Overview

10.9.2.       Service Portfolio

10.9.3.      Strategic Developments

10.9.4.       Revenue and Market Share

11.    Global Liquid Biopsy Market Competition, by Manufacturer

11.1. Global Liquid Biopsy Revenue and Market Share by Manufacturer (2017-2017)

11.2. Global Liquid Biopsy Price By Region (2017-2017)

11.3. Top 5 Liquid Biopsy Manufacturer Market Share

11.4. Market Competition Trend

12.    Liquid Biopsy Market Forecast (2017-2027)

12.1. Global Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2027)

12.2. Liquid Biopsy Market Forecast by Regions (2017-2027)

12.2.1.      North America Liquid Biopsy Market Forecast (2017-2027)

12.2.1.1. United States Liquid Biopsy Market Forecast (2017-2027)

12.2.1.2. Canada Liquid Biopsy Market Forecast (2017-2027)

12.2.1.3. Mexico Liquid Biopsy Market Forecast (2017-2027)

12.2.2.      Europe Liquid Biopsy Market Forecast (2017-2027)

12.2.2.1. Germany Liquid Biopsy Market Forecast (2017-2027)

12.2.2.2. France Liquid Biopsy Market Forecast (2017-2027)

12.2.2.3. UK Liquid Biopsy Market Forecast (2017-2027)

12.2.2.4. Russia Liquid Biopsy Market Forecast (2017-2027)

12.2.2.5. Italy Liquid Biopsy Market Forecast (2017-2027)

12.2.2.6. Rest of Europe Liquid Biopsy Market Forecast (2017-2027)

12.2.3.      Asia-Pacific Liquid Biopsy Market Forecast (2017-2027)

12.2.3.1. China Liquid Biopsy Market Forecast (2017-2027)

12.2.3.2. Japan Liquid Biopsy Market Forecast (2017-2027)

12.2.3.3. Korea Liquid Biopsy Market Forecast (2017-2027)

12.2.3.4. India Liquid Biopsy Market Forecast (2017-2027)

12.2.3.5. Southeast Asia Liquid Biopsy Market Forecast (2017-2027)

12.2.3.6. Rest of Asia-Pacific Liquid Biopsy Market Forecast (2017-2027)

12.2.4.      South America Liquid Biopsy Market Forecast (2017-2027)

12.2.4.1. Brazil Liquid Biopsy Market Forecast (2017-2027)

12.2.4.2. Argentina Liquid Biopsy Market Forecast (2017-2027)

12.2.4.3. Columbia Liquid Biopsy Market Forecast (2017-2027)

12.2.4.4. Rest of South America Liquid Biopsy Market Forecast (2017-2027)

12.2.5.      Middle East and Africa Liquid Biopsy Market Forecast (2017-2027)

12.2.5.1. Saudi Arabia Liquid Biopsy Market Forecast (2017-2027)

12.2.5.2. United Arab Emirates Liquid Biopsy Market Forecast (2017-2027)

12.2.5.3. Egypt Liquid Biopsy Market Forecast (2017-2027)

12.2.5.4. Nigeria Liquid Biopsy Market Forecast (2017-2027)

12.2.5.5. South Africa Liquid Biopsy Market Forecast (2017-2027)

12.2.5.6. Turkey Liquid Biopsy Market Forecast (2017-2027)

12.2.5.7. Rest of Middle East and Africa Liquid Biopsy Market Forecast (2017-2027)

12.3. Liquid Biopsy Market Forecast by Application (2017-2027)

12.3.1.      Liquid Biopsy Forecast by Application (2017-2027)

12.3.2.      Liquid Biopsy Market Share Forecast by Application (2017-2027)

12.4. Liquid Biopsy Market Forecast by Sample Type (2017-2027)

12.4.1.      Liquid Biopsy Forecast by Sample Type (2017-2027)

12.4.2.      Liquid Biopsy Market Share Forecast by Sample Type (2017-2027)

12.5. Liquid Biopsy Market Forecast by Biomaker Type (2017-2027)

12.5.1.      Liquid Biopsy Forecast by Biomaker Type (2017-2027)

12.5.2.      Liquid Biopsy Market Share Forecast by Biomaker Type (2017-2027)

12.6. Liquid Biopsy Market Forecast by Technology (2017-2027)

12.6.1.      Liquid Biopsy Forecast by Technology (2017-2027)

12.6.2.      Liquid Biopsy Market Share Forecast by Technology (2017-2027)

List of Tables

13. List of Tables and Figures
Figure United States Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Liquid Biopsy Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Liquid Biopsy Revenue and Revenue Share by Application (2017-2018)
Figure Global Therapy Selection for Metastatic Breast Cancer (MBS) Revenue and Growth Rate (2017-2018)
Figure Global Molecular Health Monitoring Revenue and Growth Rate (2017-2018)
Figure Global Therapy Selection for Other Metastatic Cancer Revenue and Growth Rate (2017-2018)
Table Global Liquid Biopsy Revenue and Revenue Share by Sample Type (2017-2018)
Figure Global Blood Sample-based Revenue and Growth Rate (2017-2018)
Figure Global Urine Sample-based Revenue and Growth Rate (2017-2018)
Figure Global Other Bio Fluids Revenue and Growth Rate (2017-2018)
Table Global Liquid Biopsy Revenue and Revenue Share by Biomaker Type (2017-2018)
Figure Global Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2018)
Figure Global Exosomes Revenue and Growth Rate (2017-2018)
Figure Global Circulating Tumor DNA (ctDNA) Revenue and Growth Rate (2017-2018)
Table Global Liquid Biopsy Revenue and Revenue Share by Technology (2017-2018)
Figure Global Single Gene Analysis (PCR Microarrays) Revenue and Growth Rate (2017-2018)
Figure Global Multi-gene-parallel Analysis Revenue and Growth Rate (2017-2018)
Table Global Liquid Biopsy Revenue by Regions (2017-2018)
Figure North America Liquid Biopsy Growth Rate (2017-2018)
Figure North America Liquid Biopsy Revenue and Growth Rate (2017-2018)
Figure North America Liquid Biopsy by Countries (2017-2018)
Figure North America Liquid Biopsy Revenue (Million USD) by Countries (2017-2018)
Figure United States Liquid Biopsy Growth Rate (2017-2018)
Figure United States Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Liquid Biopsy Growth Rate (2017-2018)
Figure Canada Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Liquid Biopsy Growth Rate (2017-2018)
Figure Mexico Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Liquid Biopsy Growth Rate (2017-2018)
Figure Europe Liquid Biopsy Revenue and Growth Rate (2017-2018)
Figure Europe Liquid Biopsy by Countries (2017-2018)
Figure Europe Liquid Biopsy Revenue (Million USD) by Countries (2017-2018)
Figure Germany Liquid Biopsy Growth Rate (2017-2018)
Figure Germany Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Liquid Biopsy Growth Rate (2017-2018)
Figure France Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Liquid Biopsy Growth Rate (2017-2018)
Figure UK Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Liquid Biopsy Growth Rate (2017-2018)
Figure Russia Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Liquid Biopsy Growth Rate (2017-2018)
Figure Italy Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Liquid Biopsy Growth Rate (2017-2018)
Figure Rest of Europe Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Liquid Biopsy Growth Rate (2017-2018)
Figure Asia-Pacific Liquid Biopsy Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Liquid Biopsy by Countries (2017-2018)
Figure Asia-Pacific Liquid Biopsy Revenue (Million USD) by Countries (2017-2018)
Figure China Liquid Biopsy Growth Rate (2017-2018)
Figure China Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Liquid Biopsy Growth Rate (2017-2018)
Figure Japan Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Liquid Biopsy Growth Rate (2017-2018)
Figure Korea Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Liquid Biopsy Growth Rate (2017-2018)
Figure India Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Liquid Biopsy Growth Rate (2017-2018)
Figure Southeast Asia Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Liquid Biopsy Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Liquid Biopsy Growth Rate (2017-2018)
Figure South America Liquid Biopsy Revenue and Growth Rate (2017-2018)
Figure South America Liquid Biopsy by Countries (2017-2018)
Figure South America Liquid Biopsy Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Liquid Biopsy Growth Rate (2017-2018)
Figure Brazil Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Liquid Biopsy Growth Rate (2017-2018)
Figure Argentina Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Liquid Biopsy Growth Rate (2017-2018)
Figure Columbia Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Liquid Biopsy Growth Rate (2017-2018)
Figure Rest of South America Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Liquid Biopsy Growth Rate (2017-2018)
Figure Middle East and Africa Liquid Biopsy Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Liquid Biopsy by Countries (2017-2018)
Figure Middle East and Africa Liquid Biopsy Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Liquid Biopsy Growth Rate (2017-2018)
Figure Saudi Arabia Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Liquid Biopsy Growth Rate (2017-2018)
Figure United Arab Emirates Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Liquid Biopsy Growth Rate (2017-2018)
Figure Egypt Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Liquid Biopsy Growth Rate (2017-2018)
Figure Nigeria Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Liquid Biopsy Growth Rate (2017-2018)
Figure South Africa Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Liquid Biopsy Growth Rate (2017-2018)
Figure Turkey Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Liquid Biopsy Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Liquid Biopsy Revenue (Millions USD) and Growth Rate (2017-2018)
Table Personal Genome Diagnostics Liquid Biopsy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table TrovaGene Liquid Biopsy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Guardant Health Liquid Biopsy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Raindance Technologies Liquid Biopsy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Adaptive Biotechnologies Liquid Biopsy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Qiagen Liquid Biopsy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cynvenio Biosystems Inc Liquid Biopsy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Biocept Liquid Biopsy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table NeoGenomics Liquid Biopsy Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Liquid Biopsy Market Share by Manufacturer
Figure Global Liquid Biopsy Revenue and Market Share by Manufacturer
Table Global Liquid Biopsy Price by Region (2017-2017)
Figure Top 5 Liquid Biopsy Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Liquid Biopsy Revenue (Millions USD) and Growth Rate (2018-2025)
Table Liquid Biopsy Market Forecast by Regions (2018-2025)
Figure North America Liquid Biopsy Market Forecast (2018-2025)
Figure United States Liquid Biopsy Market Forecast (2018-2025)
Figure Canada Liquid Biopsy Market Forecast (2018-2025)
Figure Mexico Liquid Biopsy Market Forecast (2018-2025)
Figure Europe Liquid Biopsy Market Forecast (2018-2025)
Figure Germany Liquid Biopsy Market Forecast (2018-2025)
Figure France Liquid Biopsy Market Forecast (2018-2025)
Figure UK Liquid Biopsy Market Forecast (2018-2025)
Figure Russia Liquid Biopsy Market Forecast (2018-2025)
Figure Italy Liquid Biopsy Market Forecast (2018-2025)
Figure Rest of Europe Liquid Biopsy Market Forecast (2018-2025)
Figure Asia-Pacific Liquid Biopsy Market Forecast (2018-2025)
Figure China Liquid Biopsy Market Forecast (2018-2025)
Figure Japan Liquid Biopsy Market Forecast (2018-2025)
Figure Korea Liquid Biopsy Market Forecast (2018-2025)
Figure India Liquid Biopsy Market Forecast (2018-2025)
Figure Southeast Asia Liquid Biopsy Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Liquid Biopsy Market Forecast (2018-2025)
Figure South America Liquid Biopsy Market Forecast (2018-2025)
Figure Brazil Liquid Biopsy Market Forecast (2018-2025)
Figure Argentina Liquid Biopsy Market Forecast (2018-2025)
Figure Columbia Liquid Biopsy Market Forecast (2018-2025)
Figure Rest of South America Liquid Biopsy Market Forecast (2018-2025)
Figure Middle East and Africa Liquid Biopsy Market Forecast (2018-2025)
Figure Saudi Arabia Liquid Biopsy Market Forecast (2018-2025)
Figure United Arab Emirates Liquid Biopsy Market Forecast (2018-2025)
Figure Egypt Liquid Biopsy Market Forecast (2018-2025)
Figure Nigeria Liquid Biopsy Market Forecast (2018-2025)
Figure South Africa Liquid Biopsy Market Forecast (2018-2025)
Figure Turkey Liquid Biopsy Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Liquid Biopsy Market Forecast (2018-2025)
Figure Global Liquid Biopsy Forecast by Application (2018-2025)
Figure Global Liquid Biopsy Market Share Forecast by Application (2018-2025)
Figure Global Liquid Biopsy Forecast by Application (2018-2025)
Figure Global Liquid Biopsy Forecast by Sample Type (2018-2025)
Figure Global Liquid Biopsy Market Share Forecast by Sample Type (2018-2025)
Figure Global Liquid Biopsy Forecast by Sample Type (2018-2025)
Figure Global Liquid Biopsy Forecast by Biomaker Type (2018-2025)
Figure Global Liquid Biopsy Market Share Forecast by Biomaker Type (2018-2025)
Figure Global Liquid Biopsy Forecast by Biomaker Type (2018-2025)
Figure Global Liquid Biopsy Forecast by Technology (2018-2025)
Figure Global Liquid Biopsy Market Share Forecast by Technology (2018-2025)
Figure Global Liquid Biopsy Forecast by Technology (2018-2025)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*